Statistical validation of endophenotypes using a surrogate endpoint analytic analogue
- 4 February 2009
- journal article
- research article
- Published by Wiley in Genetic Epidemiology
- Vol. 33 (6) , 549-558
- https://doi.org/10.1002/gepi.20407
Abstract
Endophenotypes, which involve the same biological pathways as diseases but presumably are closer to the relevant gene actions than diagnostic phenotypes, have emerged as an important concept in the genetic studies of complex diseases. In this report, we develop a formal statistical methodology for validating endophenotypes. The proposed method was motivated by the conditioning strategy used for surrogate endpoints commonly seen in clinical research. We define an endophenotype to be “a trait for which a test of null hypothesis of no genetic heritability implies the corresponding null hypothesis based on the phenotype of interest”. An index, the proportion of heritability explained, is used as an operational criterion of validation. Statistical inferences on this index are also developed. Usefulness of the proposed method is demonstrated through computer simulations and a study of assessing the Continuous Performance Test as an endophenotype of the schizophrenia spectrum. Genet. Epidemiol. 33:549–558, 2009.Keywords
This publication has 25 references indexed in Scilit:
- Using endophenotypes for pathway clusters to map complex disease genesGenetic Epidemiology, 2006
- The Endophenotype Concept in Psychiatry: Etymology and Strategic IntentionsAmerican Journal of Psychiatry, 2003
- On the Use of Surrogate End Points in Randomized TrialsJournal of the Royal Statistical Society Series A: Statistics in Society, 2000
- Joint Multipoint Linkage Analysis of Multivariate Qualitative and Quantitative Traits. I. Likelihood Formulation and Simulation ResultsAmerican Journal of Human Genetics, 1999
- Multipoint Quantitative-Trait Linkage Analysis in General PedigreesAmerican Journal of Human Genetics, 1998
- Approximate Inference in Generalized Linear Mixed ModelsJournal of the American Statistical Association, 1993
- Statistical validation of intermediate endpoints for chronic diseasesStatistics in Medicine, 1992
- DSM–III Major Depressive Disorder in the CommunityThe British Journal of Psychiatry, 1989
- A continuous performance test of brain damage.Journal of Consulting Psychology, 1956